Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-01-11

Clinical Trial Update: Vitamin D, Insulin Resistance and Inflammation in ESRD [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial evaluating the effects of Vitamin D on insulin resistance and inflammation in patients with end-stage renal disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D (Cholecalciferol)

Snippet

Sponsor: Vanderbilt University | Conditions: End Stage Renal Disease | Phase 2 | Status: COMPLETED